Mohamad Navab,
#157,965
Most Influential Person Now
Mohamad Navab,'s AcademicInfluence.com Rankings
Mohamad Navab,engineering Degrees
Engineering
#6693
World Rank
#8029
Historical Rank
Bioengineering
#72
World Rank
#74
Historical Rank
Mohamad Navab,philosophy Degrees
Philosophy
#8992
World Rank
#12481
Historical Rank
Logic
#5998
World Rank
#7468
Historical Rank
Download Badge
Engineering Philosophy
Why Is Mohamad Navab, Influential?
(Suggest an Edit or Addition)Mohamad Navab,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
- Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. (1995) (1852)
- Antiinflammatory Properties of HDL (2004) (1249)
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. (1995) (1204)
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
- Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. (1990) (1182)
- Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis (1998) (1098)
- Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins (1990) (804)
- Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. (1995) (803)
- Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * (1997) (758)
- Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. (1991) (751)
- The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. (1996) (750)
- Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL (2004) (666)
- Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. (2000) (583)
- Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment (2003) (581)
- Ambient Particulate Pollutants in the Ultrafine Range Promote Early Atherosclerosis and Systemic Oxidative Stress (2008) (561)
- HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms (2011) (535)
- Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* (2001) (467)
- HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. (2001) (447)
- Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. (1995) (425)
- Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol (2002) (410)
- Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. (2006) (390)
- Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. (2000) (387)
- Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids (2001) (367)
- A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. (2001) (357)
- Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice (2004) (333)
- Pulsatile Versus Oscillatory Shear Stress Regulates NADPH Oxidase Subunit Expression: Implication for Native LDL Oxidation (2003) (325)
- Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis: The Los Angeles Atherosclerosis Study (2001) (324)
- Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. (1997) (323)
- Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. (1997) (314)
- High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection (2001) (309)
- Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. (1996) (264)
- High-density lipoprotein function recent advances. (2005) (262)
- Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. (1999) (251)
- Mechanisms of Disease: proatherogenic HDL—an evolving field (2006) (243)
- Apolipoprotein A-I mimetic peptides (2009) (219)
- Minimally modified low density lipoprotein is biologically active in vivo in mice. (1991) (217)
- Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. (2001) (214)
- patient-oriented and epidemiological research Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients (2008) (208)
- Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein* (1999) (205)
- Paraoxonase and coronary heart disease. (2002) (205)
- The paraoxonase gene family and atherosclerosis. (2005) (193)
- Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. (1997) (189)
- Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer (2010) (188)
- Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide (2002) (182)
- Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis (2003) (179)
- Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation (2005) (179)
- Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. (1999) (175)
- The role of high-density lipoproteins in oxidation and inflammation. (2001) (171)
- NOTCH1 is a mechanosensor in adult arteries (2017) (171)
- Treponema pallidum invades intercellular junctions of endothelial cell monolayers. (1988) (167)
- Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes (2011) (159)
- A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. (2001) (157)
- Oxidized Lipids in Atherogenesis: Formation, Destruction and Action (1997) (157)
- Monocyte recruitment to endothelial cells in response to oscillatory shear stress (2003) (157)
- Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins (2006) (153)
- The role of high-density lipoprotein in inflammation. (2005) (150)
- D-4F and Statins Synergize to Render HDL Antiinflammatory in Mice and Monkeys and Cause Lesion Regression in Old Apolipoprotein E–Null Mice (2005) (147)
- Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. (2008) (147)
- HDL metabolism and activity in chronic kidney disease (2010) (145)
- The double jeopardy of HDL (2005) (143)
- Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function[S] (2011) (142)
- Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. (2009) (141)
- Diesel Exhaust Induces Systemic Lipid Peroxidation and Development of Dysfunctional Pro-Oxidant and Pro-Inflammatory High-Density Lipoprotein (2013) (135)
- HDL-inflammatory index correlates with poor outcome in hemodialysis patients. (2007) (128)
- Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention (2006) (125)
- Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6* (2001) (125)
- Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Published, JLR Papers in Press, June 14, 2007. (2007) (121)
- D-4F, an Apolipoprotein A-I Mimetic Peptide, Inhibits the Inflammatory Response Induced by Influenza A Infection of Human Type II Pneumocytes (2004) (118)
- Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis. (1998) (118)
- Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. (1988) (116)
- Oxidized lipids as mediators of coronary heart disease (2002) (115)
- In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. (2009) (115)
- Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein* (2009) (113)
- HDL as a Biomarker, Potential Therapeutic Target, and Therapy (2009) (111)
- Apolipoprotein A-I mimetic peptides. (2005) (109)
- Structure and function of HDL mimetics. (2010) (108)
- Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits Published, JLR Papers in Press, August 10, 2007. (2007) (107)
- An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice (2005) (104)
- Endothelial Cell Dynamics under Pulsating Flows: Significance of High Versus Low Shear Stress Slew Rates (∂τ/∂τ) (2002) (93)
- Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice[S] (2013) (92)
- High-density lipoprotein: Antioxidant and anti-inflammatory properties (2007) (90)
- High density associated enzymes: their role in vascular biology. (1998) (88)
- Paradoxical Reduction of Fatty Streak Formation in Mice Lacking Endothelial Nitric Oxide Synthase (2002) (88)
- Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal (2004) (84)
- Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis (2015) (83)
- Anti-Inflammatory Properties of HDL (2004) (82)
- Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. (2000) (81)
- High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment (2007) (81)
- Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. (2006) (80)
- Understanding changes in high density lipoproteins during the acute phase response. (2006) (80)
- Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice (2007) (79)
- Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p (2014) (77)
- Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo. (1995) (76)
- A novel approach to oral apoA-I mimetic therapy[S] (2013) (76)
- Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension. (1994) (76)
- Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity* (2004) (75)
- A biochemical fluorometric method for assessing the oxidative properties of HDL[S] (2011) (72)
- Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J). (2000) (70)
- Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S] (2011) (70)
- D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Published, JLR Papers in Press, July 12, 2006. (2006) (69)
- All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. (1999) (67)
- Oral Small Peptides Render HDL Antiinflammatory in Mice and Monkeys and Reduce Atherosclerosis in ApoE Null Mice (2005) (67)
- L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. (2011) (67)
- A complex flow pattern of low shear stress and flow reversal promotes monocyte binding to endothelial cells. (2001) (66)
- Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E–Null Mice (2003) (66)
- PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity Published, JLR Papers in Press, July 16, 2004. DOI 10.1194/jlr.M400053-JLR200 (2004) (66)
- Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes (2010) (66)
- Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S] (2013) (65)
- D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice[S] (2012) (64)
- Rat plasma prealbumin. Metabolic studies on effects of vitamin A status and on tissue distribution. (1977) (64)
- HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer (2012) (64)
- POLYUNSATURATED FATTY ACIDS AND TOCOPHEROL LEVELS IN PATIENTS WITH CYSTIC FIBROSIS * (1972) (64)
- Pulsatile Flow Regulates Monocyte Adhesion to Oxidized Lipid–Induced Endothelial Cells (2001) (64)
- Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance. (1986) (63)
- Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. (1988) (62)
- D‐4F, an apoA‐I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD (2012) (62)
- Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. (1991) (60)
- Inflammation and metabolic disorders (2008) (59)
- L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. (2010) (58)
- D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet Published, JLR Papers in Press, October 9, 2007. (2008) (58)
- Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. (2000) (57)
- Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites (2017) (57)
- Monocyte adhesion and transmigration in atherosclerosis. (1994) (56)
- Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice (2007) (55)
- High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. (2012) (55)
- A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids (2009) (55)
- Mitogen-activated Protein Kinase Phosphatase 1 Activity Is Necessary for Oxidized Phospholipids to Induce Monocyte Chemotactic Activity in Human Aortic Endothelial Cells* (2001) (52)
- Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis (2010) (51)
- Rat plasma prealbumin. Isolation and partial characterization. (1977) (49)
- Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis. (2008) (48)
- Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial (2017) (47)
- Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis. (1993) (47)
- Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease. (2011) (46)
- Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. (2011) (41)
- Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis (2015) (41)
- Micro Sensors: Linking Real-Time Oscillatory Shear Stress with Vascular Inflammatory Responses (2004) (39)
- Apolipoprotein A-I Mimetic Peptides Inhibit Expression and Activity of Hypoxia-Inducible Factor-1α in Human Ovarian Cancer Cell Lines and a Mouse Ovarian Cancer Model (2012) (38)
- Apolipoprotein A-I mimetics (2014) (38)
- Potential Role for Mitogen-Activated Protein Kinase Phosphatase-1 in the Development of Atherosclerotic Lesions in Mouse Models (2004) (38)
- ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells (2002) (38)
- Proinflammatory High-Density Lipoprotein Results from Oxidized Lipid Mediators in the Pathogenesis of Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension (2015) (35)
- Modifying the anti-inflammatory effects of high-density lipoprotein (2007) (35)
- Atmospheric ultrafine particles promote vascular calcification via the NF-κB signaling pathway. (2013) (35)
- High-density lipoprotein and the dynamics of atherosclerotic lesions. (2001) (35)
- Modified Lipoproteins and Atherogenesis (1992) (34)
- Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. (2003) (34)
- Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins. (2013) (33)
- ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein (1984) (33)
- L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation (2010) (32)
- Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice (2012) (31)
- Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms. (2009) (31)
- Lipoprotein receptors and endothelial cells. (1988) (30)
- Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells (2020) (30)
- Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. (2008) (30)
- The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis. (2008) (29)
- Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. (2011) (29)
- A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells. (1993) (29)
- Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides (2008) (28)
- Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS. (2013) (28)
- HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL (2011) (28)
- Apolipoprotein E−/− Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function (2016) (28)
- Apo A-1 mimetic peptides as atheroprotective agents in murine models. (2008) (27)
- High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells. (1999) (26)
- Identification of genes induced by oxidized phospholipids in human aortic endothelial cells. (2002) (26)
- Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties (2016) (25)
- Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer (2018) (24)
- D-4 F , an Apolipoprotein A-I Mimetic Peptide , Inhibits the Inflammatory Response Induced by Influenza A Infection of Human Type II Pneumocytes (2004) (24)
- Peptide Mimetics of Apolipoproteins Improve HDL Function. (2007) (23)
- Potential clinical utility of high-density lipoprotein-mimetic peptides (2006) (23)
- Oral amphipathic peptides as therapeutic agents (2006) (22)
- A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors. (2007) (22)
- Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity (2012) (22)
- Antibody to poliovirus genome-linked protein (VPg) precipitates in vitro synthesized RNA attached to VPg-precursor polypeptide(s). (1984) (21)
- Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer (2015) (20)
- Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. (2010) (20)
- Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD[S] (2016) (20)
- Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. (2010) (19)
- Searching for a Successful HDL-based Treatment Strategy. (2013) (18)
- Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma (2011) (18)
- High-Density Lipoprotein and 4 F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism Novel Hypotheses and Review of Literature (2012) (17)
- Small lipidated anti-obesity compounds derived from neuromedin U. (2015) (15)
- Minimally Modified Lipoproteins in Diabetes (1992) (15)
- Abstract 11083: A Novel Approach to Oral ApoA-I Mimetic Therapy (2012) (15)
- Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation[S] (2015) (15)
- Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension (2020) (13)
- Adipocyte Phospholipid Transfer Protein and Lipoprotein Metabolism (2015) (12)
- Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum (2017) (12)
- The effect of HDL mimetic peptide 4F on PON1. (2010) (12)
- Protective Action of HDL-Associated PON1 Against LDL Oxidation (2002) (11)
- Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice (2018) (11)
- An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I. (2005) (11)
- Synthetic peptides: managing lipid disorders (2006) (9)
- A new anti-inflammatory leucine derivative, NPC-15669, inhibits growth of cultured human aortic smooth muscle cells. (1993) (8)
- Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids (2010) (8)
- Abstract 1496: Oral Administration of the Apolipoprotein A-I Mimetic Peptide D-4F in Humans with CHD Improves HDL Anti-Inflammatory Function After a Single Dose (2006) (7)
- Transport of low density lipoproteins across endothelial monolayers. (1990) (7)
- Searching for a successful HDL-based treatment strategy. (2014) (7)
- ApoA-I Mimetic Peptides: A Review of the Present Status (2015) (6)
- Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation (2021) (6)
- Dyslipidemia and cardiovascular diseases (2009) (5)
- Anti-In fl ammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes (2011) (5)
- Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides. (2007) (5)
- Apolipoprotein a-i mimetic peptide 4f blocks sphingomyelinase-induced ldl aggregation: Interaction of the amphipathic helical peptide with ldl particles (2014) (5)
- Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model (2017) (3)
- Multiple indications for anti-inflammatory peptides (2010) (3)
- Role of host lipid metabolism and tissue macrophages in psoriasis (147.30) (2011) (3)
- HDL and Inflammation (2008) (3)
- Abstract 581: The Ability Of Apolipoprotein A-I Mimetic Peptides To Improve HDL Anti-inflammatory Properties Is Due To Their Remarkable Binding Affinities For Oxidized Lipids. (2007) (2)
- Epoxyisoprostane E2-containing phospholipids in oxidized low density lipoprotein and atherosclerotic lesions (1999) (2)
- Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a). (2004) (2)
- Cellular Interactions of the Arterial Wall (1992) (2)
- ATPIsRequired forInitiation ofPoliovirus RNA Synthesis InVitro: Demonstration ofTyrosine-Phosphate Linkage BetweenInVitro- Synthesized RNA andGenome-Linked Protein (1984) (2)
- Do dietary fatty acids cause endothelial activation? How might endothelial activation contribute to thrombogenesis? (1992) (2)
- PROOF COPY 013205ABE Endothelial Cell Dynamics under Pulsating Flows: Significance of High Versus Low Shear Stress Slew Rates "Õt… (2002) (2)
- Endothelial Cells: The Living Sensors and Actuators (2002) (1)
- Coronary artery disease in Iranian diabetic and nondiabetic patients is associated with ratio of apolipoprotein A-I/B and apolipoprotein B, but not with paraoxonase enzyme activity (2000) (1)
- Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity (2012) (1)
- Microbiome/Metabolic Syndrome/Diabetes and CVD (2015) (1)
- Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats (2010) (1)
- Macrophage lipoprotein metabolism in atherosclerosis (1985) (1)
- ApoA-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p (2014) (1)
- ApoA-I Mimetic Peptides as Anti-Inflammatory Agents (2005) (1)
- Near Term Prospects for Ameliorating Cardiovascular Aging (2010) (1)
- Transgenic Tomatoes Expressing the 6 F Peptide and Ezetimibe Prevent Diet-induced Increases of Interferon-b and Cholesterol 25-hydroxylase in Jejunum (2017) (1)
- Protection against ischemia/reperfusion injury by high-density lipoprotein and its components. (2013) (1)
- Abstract 303: HDL Mimetic Peptide 4F Rescues Pre-existing Pulmonary Hypertension via MicroRNA 193-3p (2013) (0)
- Reducing plasma cholesterol is not the end of the quest. (2013) (0)
- EVALUATION OF IRAN-DEFICIENCY ANEMIA BY SERUM FERRITIN ASSAY IN SEVE-YEAR-OLD CHILDREN (1979) (0)
- Bioactivity of LDL modified by artery wall cells is transferable to albumin (1994) (0)
- Abstract 17749: Rescue of Established Pulmonary Hypertension by a High Density Lipoprotein Mimetic Peptide (2012) (0)
- Syddansk Universitet Apolipoprotein A-I mimetic peptide 4 F blocks sphingomyelinase-induced LDL aggregation (2015) (0)
- Abstract 20623: HDL Mimetic Peptide 4F Prevents Western Diet-Induced Pulmonary Hypertension and Right Ventricular Dysfunction in LDL-Receptor Deficient Mice (2016) (0)
- Novel Plasma Biomarker Candidates in Patients With Congestive Heart Failture (2010) (0)
- Abstract 11679: Similarities Between the Villi of the Jejunum and the Human Artery Wall May Contribute to Diet-Induced Dyslipidemia and Systemic Inflammation in LDLR Null Mice (2015) (0)
- Abstract 1334: D-4F Treatment Decreases the Association of Altered Hemoglobin and its Scavengers with High Density Lipoprotein in Mice. (2006) (0)
- Anti-inflammatory properties of HDL. (2004) (0)
- Functional evidence of lipoprotein high density (2001) (0)
- Abstract 1333: Amphipathic Helical Peptides Increase ApoA-I Synthesis and Secretion from Caco2 Cells Via Transcription Factor Regulation (2006) (0)
- Use of recombinant adenovirus to facilitate gene delivery into human vascular cells in vitro (1994) (0)
- 385 USE OF LIPID LOWERING THERAPY IS ASSOCIATED WITH IMPROVED HDL FUNCTION IN METABOLIC SYNDROME AND CORONARY HEART DISEASE PATIENTS, EVEN WITH COMPARABLE LDL, HDL, AND TRIGLYCERIDE LEVELS (2005) (0)
- High Density Lipoprotein the Inflammatory Properties and Function ApoA-1-containing Particles and Influence Haptoglobin Associate with Hemoglobin and Its Scavenger Protein Regulation , and Signaling : Lipids and Lipoproteins : Metabolism (2009) (0)
- NOTCH1 is a mechanosensor in adult arteries (2017) (0)
- Peptides administered orally to enhance atherosclerosis. (2001) (0)
- Abstract 17778: Estrogen-induced Rescue of Pre-existing Severe Pulmonary Hypertension is Associated with Restoration of Elevated Plasma Oxidized Lipids and Eicosanoids (2012) (0)
- Apolipoprotein-A1 Mimetic Peptide 4F Rescues Pre-Existing Severe Pulmonary Hypertension And Right Ventricular Dysfunction (2012) (0)
- W09-P-012 ApoA-I is required for HDL anti-atherogenic function in vivo (2005) (0)
- Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer (2018) (0)
- Abstract 14930: Role of the Enterocyte Enpp2 Gene in Western Diet-induced Systemic Inflammation (2017) (0)
- Abstract 1641: Altered Hemoglobin is Associated with High Density Lipoproteins in Sera from Mice Fed Atherogenic/Hyperlipidemic Diets (2006) (0)
- Abstract 1642: Feeding a Western Diet to LDL Receptor Null Mice Causes Inflammatory Changes in the Glomerulus, which are Ameliorated by D-4F an Apolipoprotein A-I Mimetic (2006) (0)
- Abstract # 16088: ApoA-I Mimetic Peptide Prevents Atherosclerosis Development and Reduces Plaque Inflammation In A Mouse Model of Diabetes (2010) (0)
- Abstract 1612: L-4F Inhibits Platelet Aggregation and Prolongs Bleeding Time by Inhibiting the Formation of Arachidonic Acid Metabolites in Apo-E Null Mice (2009) (0)
- Hemoglobin , haptoglobin and hemopexin play a role in HDL inflammatory properties 1 Hemoglobin and its scavenger protein haptoglobin associate with apoA-1 containing particles and influence the inflammatory properties and function of high density lipoprotein (2009) (0)
- Adipocyte-Specific PLTP Deficiency Decreases Plasma PLTP Activity (0)
- JLR 2015/064352 Revision #1 Tomatoes expressing the 6F Peptide Ameliorate the Increase in Oxidized Phospholipids in the Jejunum of Mice Fed Unsaturated Lysophosphatidylcholine or Western Diet (2015) (0)
- Abstract 14968: Role of Lysophosphatidylcholine 18:1 in Enterocytes of LDLR Null Mice on Western Diet (2017) (0)
- Atherosclerosis Atherosclerosis in Dyslipidemic Obese Mice : LCAT Gene Transfer Decreases Antioxidant Defense Are Associated With Increased Macrophage Homing and Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein (2003) (0)
- Abstract 14074: Oral ApoA-I Mimetic Tg6F Enhances Ezetimibe Amelioration of Dyslipidemia (2016) (0)
- Abstract 393: Lipoprotein Inflammatory Properties But Not Cholesterol Levels Predict Lesion Area in Cholesterol-fed Rabbits (2007) (0)
- Systemic Oxidative Stress Ambient Particulate Pollutants in the Ultrafine Range Promote Early (2008) (0)
- Abstract 19163: A Novel Key Role of LDL and its Receptor in Pre-clinical and Clinical Pulmonary Hypertension (2017) (0)
- Abstract P141: Gender Differences in the Development of Severe Pulmonary Hypertension and Right Ventricular Dysfunction in Apolipoprotein E--Deficient Mice Are Eliminated with Increasing Age (2011) (0)
- Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis. (2023) (0)
- Oral Administration of the Apolipoprotein A-1 Mimetic Peptide D-4f Promotes Cholesterol Efflux and Inhibits Atherosclerosis Progression in Chow-Fed Low Density Lipoprotein Receptor /apobec-1 Null Mice Even in the Absence of Endogenous Apolipoprotein A-1 (2006) (0)
- Tu1848 Chronic Oral Exposure to Ultrafine Particulate Matter Alters the Cecal Microbiota Composition but Not Ileal Permeability in LDLR-Null Male Mice Fed a High Fat Diet (2016) (0)
- Biological effects of minimally oxidized lipoproteins (1994) (0)
- Enzymes and Proteins that are Associated with High Density Lipoprotein and their Role in the Anti-Inflammatory Capacity of HDL (1996) (0)
- Abstract 386: Air Pollutants Induce Dysfunctional Prooxidant HDL and Activate 5-lipoxygenase in the Liver (2013) (0)
- Abstract 9179: Free Oxidized Fatty Acids Contribute to Pro-Inflammatory HDL (2011) (0)
- Polyunsaturated fatty acids augment lipoxygenase-mediated oxidation of LDL resulting in biologically active lipids (1993) (0)
- Apolipoprotein A-I Mimetic Peptides in Mouse Models of Cancer (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mohamad Navab,?
Mohamad Navab, is affiliated with the following schools:
